EUR/USD 1.06532
0.094%
Gold 2393.29
0.611%
Oil 82.338
0.596%
USD/JPY 154.632
-0.010%
GBP/USD 1.23763
-0.480%
GBP/JPY 191.379
-0.488%
Browse More
  • English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
The White House: We do not want to see the conflict in the Middle East escalate.The White House: Will continue to closely monitor the oil and energy markets.The White House: No comment on reports about Israel and Iran.New York emergency department officials: Someone set himself on fire outside the court where Trumps case was being heard and was taken away on a stretcher for unknown reasons.Huntington Bank CEO: We have begun to adjust to fewer interest rate cuts (expectations).

Walmart And CVS Will Stop Processing Restricted Drug Prescriptions Written by Cerebral, Done

Aria Thomas

May 26, 2022 09:34

W1.png


Walmart (NYSE:WMT) Inc and CVS Health Corp (NYSE:CVS) announced on Wednesday that they will cease processing restricted drug prescriptions written by telehealth firms Cerebral Inc and Done Health.


Cerebral and Done are well-known for treating ADHD patients with stimulants like Adderall.


Walmart told Reuters that the decision was taken following an audit and compliance procedure.


CVS announced on May 26 that it will no longer accept restricted drug prescriptions provided by the startups, as a consequence of an investigation it did on the telehealth companies and its inability to "resolve issues we have with Cerebral and Done Health."


The Wall Street Journal was the first to announce the news early on Wednesday.


Cerebral and Done declined to comment when contacted by Reuters.


Federal prosecutors reportedly filed a subpoena to Cerebral earlier this month as part of a probe into suspected breaches of the Controlled Substances Act.


The WSJ was the first to publish the news on Wednesday.

Suggestion